Adenosine derivatives having A2A receptor activity

Details for Australian Patent Application No. 2006224764 (hide)

Owner Novartis AG

Inventors Taylor, Roger John; Fairhurst, Robin Alec

Agent Davies Collison Cave

Pub. Number AU-A-2006224764

PCT Pub. Number WO2006/097260

Priority 0505219.6 14.03.05 GB

Filing date 13 March 2006

Wipo publication date 21 September 2006

International Classifications

C07H 19/167 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A61K 31/7076 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 473/00 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 473/16 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

27 September 2007 PCT application entered the National Phase

  PCT publication WO2006/097260 Priority application(s): WO2006/097260

9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224765-CIS-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments

2006224760-Pharmaceutical tablets of crystalline Type II aripiprazole